Dolby Laboratories (NYSE:DLB) Updates FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) issued an update on its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 4.250-4.400 for the period, compared to the consensus estimate of 4.100. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q4 2026 guidance to 1.130-1.280 EPS.

Wall Street Analyst Weigh In

DLB has been the subject of several research reports. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research report on Thursday, June 11th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Dolby Laboratories presently has an average rating of “Moderate Buy” and a consensus target price of $90.75.

View Our Latest Stock Report on DLB

Dolby Laboratories Stock Down 1.6%

Shares of Dolby Laboratories stock traded down $0.85 during trading on Thursday, reaching $51.69. The company’s stock had a trading volume of 1,149,996 shares, compared to its average volume of 813,348. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $75.80. The company has a market cap of $4.89 billion, a price-to-earnings ratio of 20.43 and a beta of 0.81. The firm’s 50-day moving average is $52.25 and its two-hundred day moving average is $58.67.

Dolby Laboratories (NYSE:DLBGet Free Report) last released its earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 3.21 EPS for the current year.

Insider Buying and Selling

In other news, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This trade represents a 3.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 47,458 shares of company stock valued at $2,639,537 over the last three months. 37.93% of the stock is owned by corporate insiders.

Institutional Trading of Dolby Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Boothbay Fund Management LLC lifted its position in Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after purchasing an additional 157 shares during the last quarter. Raymond James Financial Inc. raised its holdings in Dolby Laboratories by 1.0% during the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after buying an additional 235 shares during the last quarter. Cresset Asset Management LLC raised its holdings in Dolby Laboratories by 10.7% during the 3rd quarter. Cresset Asset Management LLC now owns 2,991 shares of the electronics maker’s stock valued at $216,000 after buying an additional 290 shares during the last quarter. US Bancorp DE boosted its position in Dolby Laboratories by 31.3% during the 3rd quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after buying an additional 341 shares during the period. Finally, Cetera Investment Advisers boosted its position in Dolby Laboratories by 7.8% during the 4th quarter. Cetera Investment Advisers now owns 5,783 shares of the electronics maker’s stock valued at $371,000 after buying an additional 418 shares during the period. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.